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Abstract
Staphylococcus aureus adapts to the host environment during infection, but it is challenging to study its global in vivo response. 
In a previous study (Xu., et al. BMC Microbiol 16:80, 2016, doi: 10.1186/s12866-016-0695-6), we reported the transcriptome of 
S. aureus in a prosthetic joint infection. In this study, transcriptome of the same S. aureus strain was investigated in a guinea pig 
implant infection model. Four Teflon® cages were placed subcutaneously in each of the 12 animals before S. aureus inoculation. 
Six animals were treated with moxifloxacin for four days starting three days after infection initiation (day 3), while the other six 
remained untreated. Cage fluid and cages were collected for RNA sequencing and metabolomics. We found clear distinction of the 
expression profiles between in vivo and in vitro samples. In the untreated group, early infection (day 3) samples were characterized 
with upregulation of many virulence genes, amino acids catabolism and several fermentation pathways compared with the in vitro 
samples, while from early (day 3) to late infection (day 7 and 9) increased ammonia production was indicated by upregulation 
of urea degradation, arginine deiminase and acetoin biosynthesis pathways. The transcriptome at late stage (seven and nine days 
after infection initiation) were found not differentiable. Increasing concentrations of several amino acids and fermentation products 
were detected by metabolites analysis. The transcriptome seven days after termination of moxifloxacin treatment resembled early 
infection (day 3). Overall, the S. aureus gene expression profiles showed its dynamic adaptation to a changing environment during 
infection development.
Keywords: Staphylococcus aureus; Moxifloxacin; Biofilm; infection; gene expression; in vivo
Introduction
Staphylococcus aureus is a major cause of community- and hospital-acquired infections worldwide. S. aureus has a remarkable ability to 
adapt to a biofilm mode of growth in response to the host environment, and this is crucial for its leading role in device-related infections 
[1,2].
The pathogenesis of S. aureus infections has been studied extensively both in vitro and in vivo. Multiple virulence factors have been 
revealed such as toxins and cell surface proteins which facilitate adhesion, invasion and evasion in order to survive and hide from the 
host’s immune response [3,4]. However, few studies investigated infection progress and related changes in virulence expression [5]. In 
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addition to virulence determinants, adaption to the host environment requires adjusting metabolic activities to the changing environment 
in the host during infection development. Rohmer and co-workers [6] addressed this question in an opinion manuscript arguing that 
a pathogenic microorganism has to invade a niche that is already occupied either by human cells or by a perfectly adapted microbial 
resident.
Therefore, the ability to survive depends on the ability to adapt to changes in a hostile environment. Consequently, looking at the ability 
of pathogenic bacteria to adjust metabolic pathways might give an extra dimension in our understanding of bacterial pathogenicity.
Nonetheless, knowledge of S. aureus metabolic changes in vivo is scarce.
To describe the complicated interaction between the microorganism and the host, gene expression has been investigated both in vitro 
and in vivo at the bacterial level. It has become clear that the in vivo setting is far more complex and in vitro data cannot be translated to 
in vivo infections. S. aureus gene expression has been studied in vivo in rabbit [7], guinea pig [8], rat [9] and mice [10,11], as well as in 
humans [12,13]. Most of these studies focused on a few specific virulence determinants. To our knowledge only Date., et al. and Xu., et al. 
have studied S. aureus global gene expression in deep infections in humans [10,14].
The primary aim of this study was to study the in vivo transcription response of S. aureus during infection progression in a guinea pig 
implant-infection model and changes induced by treatment with moxifloxacin using the RNA-sequencing approach (RNA-Seq). Although 
virulence is interest of many studies, we chose to focus on the regulation of metabolic pathways, not individual virulence determinants. 
Moreover, nuclear magnetic resonance (NMR) spectroscopy was used to analyse the metabolites in fluid aspirated from the hollow 
implants at different time points to determine the biochemical compositions of the investigated environment. To do this, we chose the pan 
susceptible and biofilm-forming strain (SAU060112) from our previous study [14] to enable comparison of the in vivo gene expression 
profiles between the human prosthetic joint infection (PJI) and the guinea pig implant model. We decided to use this animal implant model 
because it is well-established [15-19] and guinea pig is highly susceptible to staphylococcal infection and its symptoms and immune 
response are similar to humans [20]. Moxifloxacin, a broad-spectrum fluoroquinolone antibiotic, was selected for treatment because of 
the toxic effect of common antibiotics such as penicillin on the gut microbiome of guinea pigs [21,22]. Moxifloxacin binds to and inhibits 
the bacterial enzymes DNA gyrase (topoisomerase II) and topoisomerase IV, resulting in inhibition of DNA replication and repair and cell 
death in sensitive bacterial species [23].
Materials and Methods
Infecting organism
S. aureus strain SAU060112 [14], a clinical isolate from a PJI patient, was used.
The bacterium was isolated directly from the primary culture plate from the prosthesis component of a PJI patient and stored in 20% 
glycerol at -80°C. This strain (spa type t908, Clonal Complex 45) is susceptible to penicillin, methicillin and 5 antibiotic classes other than 
β-lactam [14]. The inoculum was freshly prepared from an overnight LB medium agar by resuspending colonies in 0.9% sterile saline 
(NaCl). The OD600 of the inoculum was adjusted to reach a final concentration of 2 x 104
 CFU/mL. In addition, a CFU count was made for 
the inoculum.
Animal model
The research protocol was approved by the Danish Animal Ethics Council (2015-15-0201-00620), and the animals were kept and 
studied at animal facility maintained by the Department of Biomedical Research’s at Aalborg University Hospital, Aalborg, Denmark.
A modified version (changes in sex of the guinea pigs) of the established foreign-body infection model in guinea pigs was used 
[15,16]. The animals (albino female Dunkin-Hartley guinea pig, Lidköping Kaninfarm, Sweden) were acclimatised for minimum 14 days 
before subcutaneous implantation of four polytetrafluoroethylene (Teflon) cages (32 mm X Ø 10 mm and perforated with 130 spaced 
holes, Ø 1 mm) (Angst-Pfister AG, Zürich, Switzerland) in the flanks and closure of the incision by intracutaneous stitches under aseptic 
conditions. The weight of animals was 350-510g at time of implantation. The first animals were anesthetized with Hypnorm-Dormicum 
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(fentanyl/fluanisone-midazolam, 1.0 mL/kg + 2.5 mg/kg, intramuscular), but we switched to Zoletil (tiletamin + zolazepam, 0,1 mL/kg 
intramuscular) due to shorter recovery time after the anaesthesia. For 3 days post-surgery 0.1 mL Metacam (meloxicam, 0.5 mg/mL) was 
administered orally in commercial baby apple puree. Two weeks after surgery and healing of the wounds, the cage fluid was cultured to 
rule out contamination before infection. The cage fluid was cultured on 5% horse blood agar (SSI Diagnostica, Denmark) aerobically (5% 
CO2) and anaerobically on chocolate agar enforced with vitamin K and cysteine (SSI Diagnostica, Denmark) up to 14 days. None of the 
cages were contaminated and all animals were included in the study.
The experiment was designed with six animals being treated with moxifloxacin and six animals not receiving antibiotics. On day 0 the 
tissue cages were infected with 0.1 mL culture containing 2 x 103 CFU S. aureus SAU060112 by injection directly into each cage. On day  3, 
cage fluid was aspirated from a subset of cages for assessment of infection by culture as mentioned above, and remaining fluid was saved 
in RNA later (Ambion, USA) for transcriptome study. Moxifloxacin 2 x 90 mg/kg for 4 days per os was initiated in the selected animals 
on day 3 (after the aspiration). The target for the dose was a concentration of 10 μg/mL moxifloxacin at the infection site one hour after 
administration [35]. On day 7 one or two animals in each group were anesthetized, cage fluid and the cages were removed for analysis, 
and the animals were sacrificed. For the remaining animals, the cage fluid was extracted for analysis. On day 9 cage fluid and cages 
were obtained from the animals not treated with antibiotic, and they were sacrificed. This endpoint was chosen for ethical reasons. The 
procedure was the same on day 14 for the remaining animals receiving antibiotic treatment. The RNA later samples were stored at 4°C 
overnight and kept at -80°C until preparation for RNA-Seq.
Transcriptomics
All commercial kits mentioned were used according to the manufacturer’s instructions. RNA was extracted by PowerLyser® Ultraclean® 
Tissue and Cells RNA Isolations Kit (MO BIO Laboratories, USA) including On-Spin Column DNase I Kit (RNase-Free). Followed by another 
DNase treatment in the liquid phase of the extracted product as described in the On-Spin Column DNase protocol. The products were 
cleaned up by RNeasy MinElute Cleanup kit (Qiagen, USA) followed by MicroEnrich™ (Ambion®, Life Technologies) treatment, then 
another cleanup step by RNeasy MinElute Cleanup kit. The resulting products were treated with RiboZero rRNA Removal Kit (Bacteria) 
(Illumina, USA) followed by a modified RNeasy MinElute Cleanup according to the RiboZero rRNA Removal protocol before Illumina® 
TruSeq® Stranded mRNA Library Prep Kit. Libraries were paired end sequenced (2 x 141 bp) using Illumina® HiSeq 2500.
RNA data analysis
The data was analysed using the RNA-Seq tool in CLC genomic workbench (vs. 9.1, Qiagen). Reads were aligned to the annotated 
genome of SAU060112 (accession number: CCXN00000000) allowing a minimum fraction of 0.8 and a minimum similarity fraction of 
0.8. The biological replicates were grouped in the ‘RNA experiments’ and the total gene reads were normalised to neutralize the inter-
individual variations, before performing the edge R application in CLC workbench (Benjamini and Hochberg 1995; Robinson, McCarthy 
and Smyth 2010). Genes with a false discovery rate p-value < 0.05 (FDR p-value) were classified as differentially expressed; the FDR 
p-value includes the variation in the depth of sequencing between the replicates in the groups.
Samples with low coverage was removed from the sample set, which included samples with a total gene counts below 100 reads for 
the highest expressed functional genes in the gene expression profile.
Raw data from the original S. aureus human PJI and in vitro cultures (LB-medium) were retrieved from GEO Series accession number 
GSE62091 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE62091).The data was analyzed in parallel as described above.
The data have been deposited in NCBI’s Gene Expression Omnibus [36] and are accessible through GEO Series accession number 
GSE118015 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE118015).
NMR spectroscopy analysis
Prior to NMR measurements, samples were centrifuged at 4°C for 5 minutes at 12100g.
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Aliquots of 500 μL of supernatants were mixed with 100 μL 0.2 M phosphate buffer (pH 7.4, 99% D2O, containing 0.42 mM TSP-d4) 
and 10 mM NaN3. The mixture was transferred to a 5-mm NMR tube and samples were kept at 278.1 K prior to analysis, no longer than 
24h, using a Bruker AVIII-600MHz NMR spectrometer (Bruker BioSpin, Germany) equipped with a cryogenic CPP-TCI probe at 298.1 K. 
For the analysis, aT2 relaxation-edited Carr-Purcell-Meiboom-Gill (CPMG) experiment was used (“cpmgpr1d” in Bruker library, spectral 
width 20 ppm, 64 K datapoints, relaxation delay of 4s, acquisition time 2.73s, total spin-echo time 80.4 ms, 256 scans). The FID was 
multiplied with an exponential function corresponding to a line broadening of 0.3 Hz, Fourier transformed, phase- and baseline-corrected. 
Subsequently spectra were imported into ChenomX 8.2, which was used for quantification of metabolites.). For metabolite identification, 
we used Chenomx, the Human Metabolome Database [37-40] and the BRUKER BBIOREFCODE database (v. 2.7.0-4).
Results
S. aureus infections in vivo
The study design is shown in figure 1 and detailed description of the experimental procedure is given in Material and methods. Fourteen 
days after subcutaneous cage implantation and healing of wounds, S. aureus was injected directly into each cage. Prior to the injection 
all aspirates of cage fluid were confirmed culture negative. After injection, all aspirates were culture positive only for S. aureus. On day 3, 
moxifloxacin was initiated in the treatment group and lasted for four days. On day 7, one or two animals in both groups were sacrificed.
Figure 1: Flow diagram showing the experimental setup. The experiment was planned to last for 14 days, but for untreated animals  
the experiment was terminated on day 9 for ethical reasons. Abbreviations: Infection day 3: INF3; Infection day 7: INF7;  
Infection day 9: INF9; Moxifloxacin treated day 14: Treat14. Numbers in purple indicate numbers of samples analysed  
by NMR. Numbers in green indicate number of samples with sufficient reads for RNA-seq analysis.
The remaining animals in the control group were sacrificed on day 9 due to a more aggressive infection than expected, while the 
animals in the treatment group were sacrificed on day 14 as planned and none of them were cured for the infection.
RNA sequencing qualities
A total of 43 samples including cage fluids and cages were collected for RNA sequencing.
However, due to the difficulties of extracting mRNA, only 23 samples contained sufficient transcripts from S. aureus and were included 
in the transcriptomics analysis (for further detail see table S1). Except samples taken at the end of moxifloxacin treatment (day 7), three to 
nine samples at each time point comprising of both cage fluid and cage were used for further analysis. As shown in table S1, between four 
to 438 million reads were obtained for each sample, but most of them were host RNA or bacterial ribosomal RNA despite of application 
of MicroEnrichTM (Ambion, Life Technologies) and RiboZero rRNA Removal Kit (Bacteria) (Illumina). Only 0.03 - 1.57% of reads were 
mapped to protein coding sequences of the genome of the strain.
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Sample name Total reads Mapped total (%) Mapped mRNA (%) % af bacterial RNA
Infection day 3
2,1,2 46,433,080 113,813 0.25 21,887 0.05 19.23
5,4,2* 29,376,771 413,878 1.41 9,522 0.03 2.30
7,2,2* 5,586,272 10,327 0.18 5,887 0.11 57.01
8,3,2* 22,573,063 77,310 0.34 4,359 0.02 5.64
10,3,2 20,570,284 1,315,663 6.40 22,016 0.11 1.67
11,1,2 17,220,133 114,787 0.67 29,372 0.17 25.59
Infection day 7
7,2,3 9,273,787 5,222,094 56.31 70,114 0.76 1.34
8,3,3 7,618,296 171,430 2.25 119,346 1.57 69.62
10,3,3 4,909,066 491,685 10.02 57,653 1.17 11.73
11,1,3 27,042,687 1,653,048 6.11 12,501 0.05 0.76
12,4,3 29,380,090 20,149,709 68.58 54,366 0.19 0.27
12,2,B 12,329,629 997,574 8.09 83,042 0.67 8.32
12,4,B 6,215,105 861,450 13.86 14,337 0.23 1.66
11,4,3 29,575,316 8,155,006 27.57 18,823 0.06 0.23
Infection day 9
7,2,4 151,959,995 1,631,833 1.07 628,867 0.41 38.54
8,4,4 35,378,506 866,526 2.45 36,430 0.10 4.20
10,4,4 4,813,939 84,467 1.75 33,600 0.70 39.78
11,1,4 31,300,234 83,472 0.27 15,948 0.05 19.11
11,4,4* 33,036,153 98,242 0.30 6,660 0.02 6.78
7,3,B 36,346,375 24,169,872 66.50 20,805 0.06 0.09
8,4,B 15,200,972 954,277 6.28 27,626 0.18 2.89
10,3,B 20,776,709 5,985,541 28.81 27,050 0.13 0.45
10,4,B 14,866,576 151,140 1.02 25,856 0.17 17.11
11,4,B 23,154,590 2,465,153 10.65 39,765 0.17 1.61
Moxifloxacin day 7
1,1,3* 253,548 8,899 3.51 94 0.04 1.06
1,1,B* 23,800,560 2,548,189 10.71 6,869 0.03 0.27
1,2,B* 36,494,649 6,379,579 17.48 1,838 0.01 0.03
Moxifloxacin day 14
2,2,3* 30,539,980 13,372,100 43.79 7,992 0.03 0.06
2,1,3 20,544,346 560,112 2.73 27,540 0.13 4.92
4,3,3* 2,510,429 708,045 28.20 780 0.03 0.11
6,1,3* 16,369,651 1,140,827 6.97 1,189 0.01 0.10
2,1,B* 30,670,230 39,209 0.13 3,261 0.01 8.32
3,1,B 10,136,951 948,890 9.36 45,112 0.45 4.75
3,2,B 438,446,274 796,629 0.18 258,403 0.06 32.44
4,4,B* 518,747 79,201 15.27 87 0.02 0.11
6,1,B* 55,704,931 103,057 0.19 3,788 0.01 3.68
6,3,B* 53,424,072 94,701 0.18 1,674 0.00 1.77
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Figure 2: Principal component analysis of all transcriptome profiles. Green: Infection day 3 (INF3). Yellow: Infection day 7 (INF7).  
Magenta: Infection day 9 (INF9). Blue: Moxifloxacin treated day 14(Treat14). Red: Human PJI (14). Purple: S. aureus SAU060112  
culture in vitro in LB medium. Full circle: cage fluid. Hollow circle: cage. Principal component 1 separates the aerobic in vitro  
culture from the in vivo infection samples, whereas principal component 2 indicates the difference of the infection states.
Comparison of in vivo and in vitro expression profiles
Principal component analysis (PCA) showed that the in vivo S. aureus gene expression profiles were distinct from in vitro growth in LB 
medium (Figure 2), the cage fluid samples and the cage implants at the same time points were grouped together. Note that PC1 explains 
79% of the variation and PC2 only 7%, hence the major grouping is along PC1, separating the in vitro transcriptomes from the rest of 
the samples. From in vitro cultures to infection day 3, more than 400 genes were differentially expressed indicating adaption of S. aureus 
towards host environment. As expected, many virulence genes had increased transcript levels from the in vitro culture to infection day 3 
(supplemental file 2). We found the human PJI profile (sampled on the 4th day of admission) [14] to be most related to the infection day 7 
and 9 in this study, whereas the transcriptomes seven day after termination of moxifloxacin treatment (Treat14) resembled the infection 
expression profile on day 3. The output file of differential gene expression analysis can be found in supplemental file 2.
S. aureus gene expression changes during infection development in the guinea pig model
As shown in the PCA plot (Figure 2), among the in vivo samples, the expression profiles of infection day 3 grouped together with 
Treat14 and were different from infection day 7 and 9.
Furthermore, there was no discernible difference between infection day 7 and 9, therefore, the samples from those two days were 
grouped together for further analyses.
Interestingly, from infection day 3 to infection day 7 and 9, S. aureus reduced transcription of 11 known or putative virulence genes 
(chp, hly, lip, nuc, plc, rot, sak, sbi, scn, spa and entC), and iron acquisition genes (isdA, isdB, isdC, isdE, isdF, and isdG). In fact, only a single 
virulence gene (clfA) which codes for clumping factor A had increased transcription on infection day 7 and 9 compared with day 3. 
Interestingly, this gene was slightly less transcribed on infection day 3 compared with in vitro culture (3 fold). Several amino acids were 
detected by NMR in the cage fluids (Figure 3) and the concentration of these amino acids increased over time.
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Figure 3: Concentration of amino acids detected in supernatant by NMR analysis.  
The concentrations of all detected amino acids increased after infection initiation.
From infection day 3 to day 7 and 9, a total of 109 genes were found differentially transcribed, of which 61 had reduced and 48 
increased transcription on infection day 7 and 9.
Elevated concentrations of fermentation products (lactic acid, ethanol, format and acetate) were detected in the cage fluids after 
infection by metabolites analysis (Figure 4). As expected, genes coding for the fermentation pathways were more transcribed on infection 
day 3 compared with in vitro cultures (Figure 5). These included ethanol fermentation pathway (pflB, ADH, adhP) and pyruvate conversion 
to lactate (L-lactate dehydrogenase ldh). In addition, among the genes with the most increased transcription from in vitro to INF3 were 
tdcB and pflB coding for enzymes involved in the threonine degradation pathway, and ald coding for alanine dehydrogenase. Ammonia 
was produced from both processes (Figure 5).
Figure 4: Concentration of some metabolites detected in supernatant by NMR analysis.
Citation: Trine Rolighed Thomsen., et al. “Staphylococcus aureus Transcriptome during Infection and Antibiotic Treatment with  
Moxifloxacin in a Guinea Pig Biofilm Infection Model”. EC Microbiology 15.5 (2019): 344-356.
Staphylococcus aureus Transcriptome during Infection and Antibiotic Treatment with Moxifloxacin in a Guinea Pig Biofilm 
Infection Model
351
From infection day 3 to day 7 and 9, we found transcripts of α-acetolactate synthase (alsS) and α-acetolactate decarboxylase (aldB) 
elevated (Figure 6). Under anaerobic conditions these two enzymes catalyze pyruvate conversion to acetoin (Booth and Kroll 1983). 
Acetoin concentration was increased by time as detected by NMR (Figure 4). Moreover, there were more L-lactate dehydrogenase (ldh) 
transcripts on INF3, while more D-lactate dehydrogenase gene ldhD-1 was transcribed on infection day 7 and 9.
Figure 5: Metabolic pathways more transcribed on infection day 3 compared with in vitro culture.
Figure 6: Metabolic pathways more transcribed on infection day 7 and 9 compared with infection day 3.
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Furthermore, we found several genes involved in ammonia production related metabolic pathways had higher transcript level on day 
7 and 9. Urea degradation related genes were more transcribed including urease subunits alpha (ureC) and beta (ureB) as well as four 
accessory genes (ureD, ureE, ureF and ureG) necessary for the functional incorporation of the urease metallocenter. The urease enzyme 
catalyzes the hydrolysis of urea to form two molecules of ammonia. On day 3 transcription of these genes was negligible. Furthermore, 
we found increased transcript levels of genes involved in the arginine deiminase pathway on day 7 and 9. It includes the arcD gene, which 
encodes a membrane-bound arginine-ornithine antiporter, and arcABC, which codes for the enzymes converting arginine to citrulline, 
ATP and ammonia anaerobically [24]. Lastly, we found sdaAB (L-serine dehydratase, iron-sulfur-dependent, beta subunit) had increased 
expression on day 7 and 9. L-serine dehydratase converts L-serine to pyruvate and ammonium.
Effect of antibiotics treatment
Treatment with moxifloxacin shifted the gene expression profile “back to the start”, which is indicated by the resemblance of Treat14 
and infection day 3 profiles described before.
Comparing Treat14 with infection day 7 and 9, 258 genes were differentially transcribed, while 108 genes were differentially transcribed 
from infection day 3 to day 7 and 9 (Figure 7). 57 Genes were commonly differentially transcribed including eight virulence genes (chp, 
hly, nuc, rot, sak, sbi, scn and spa) and L-lactate dehydrogenase (ldh). These nine genes were least transcribed on day 7 and 9, while clfA 
and genes coding for proteins involved in several metabolic processes (urease and its accessary proteins (ureBCDEFG), arginine deiminase 
pathway (arcABCD), pyruvate fermentation to R-acetoin (alsS, aldB), and D-lactate dehydrogenase (ldhD-1)) had highest transcript level 
on day 7 and 9.
Figure 7: Venn diagram showing differentially expressed genes. 258 genes were differentially transcribed comparing Treat14  
with infection day 7 and 9 (yellow), while 108 genes were differentially transcribed from infection day 3 to day 7 and 9 (blue).
Additionally, the Treat14 group had increased transcription of the dissimilatory reduction of nitrate to ammonium (DRNA) pathway. 
The involved genes (narG, narH, narT and nasD) and the two-component regulatory system nreA/nreB/nreC had 2- to 10-fold higher 
transcript level in the Treat14 group than all the other groups.
Discussion
To understand S. aureus transcriptional changes in vivo during infection development and antibiotics treatment, we used a guinea 
pig implant infection model and performed RNA-seq analysis of the samples taken at different time points. S. aureus implant infection 
was successfully established in all 12 animals and none of the six moxifloxacin treated animals recovered. However, we only succeeded 
in obtaining sufficient mRNA reads from 23 out of 43 sequenced samples. All samples except two had less than 1% reads mapped to 
protein coding genes. It was most likely due to the combination of factors such as high amount of host RNA and bacterial ribosomal RNA, 
unavoidable loss of mRNA during RNA extraction, and low bacterial cell number. At the end of four days moxifloxacin treatment three 
samples were collected but none of them generated enough mRNA reads indicating low transcription activity of the surviving S. aureus 
(Table S1 and figure 1). Obtaining sufficient bacterial mRNA reads is a main technical challenge for studying bacterial transcriptome in 
human samples.
Citation: Trine Rolighed Thomsen., et al. “Staphylococcus aureus Transcriptome during Infection and Antibiotic Treatment with  
Moxifloxacin in a Guinea Pig Biofilm Infection Model”. EC Microbiology 15.5 (2019): 344-356.
Staphylococcus aureus Transcriptome during Infection and Antibiotic Treatment with Moxifloxacin in a Guinea Pig Biofilm 
Infection Model
353
For example, in a recent study of Pseudomonas aeruginosa transcriptome during different human infections, only 15 of 28 sequenced 
human samples had sufficient reads for analysis [25].
The PCA plot shows the clear separation between the in vitro and in vivo samples (Figure 2). Despite the difference between the hosts, 
the human PJI sample clustered near the guinea pig samples. A similar tendency has been observed by Date., et al. [10], who found that S. 
aureus gene expression profiles were remarkably similar in abscesses in humans and mice, and distinct from in vitro cultures. A set of genes 
likely important for establishment or maintenance of infection had higher transcription in vivo including numerous proteases, toxins, and 
transporters [10]. Unsurprisingly, we found that compared with in vitro samples many virulence genes were transcribed at higher level 
on infection day 3, but as the infection developed, S. aureus reduced transcription for 11 of them on infection day 7 and 9. The PCA plot 
also shows clustering of infection day 7 and 9 samples indicating stabilization of the infection expression profile. The up- and down-
regulation of virulence genes illustrated the fine-tuning of transcriptome by S. aureus to adapt to the challenging environment in course 
of the infection. Clumping factor A was the only virulence gene upregulated on infection day 7 and 9. This protein is known as fibrinogen-
binding surface protein and inhibits phagocytosis by human polymorphonuclear leukocytes [26]. In a previous study [27] which also used 
the guinea pig implant infection model, clfA transcript level was shown to be highest late during growth in vivo in agreement with our 
observation. In addition, the cage and cage fluid samples were clustered together in the PCA plot, which was surprising because the cage 
samples were expected to contain mostly biofilm whereas planktonic cells were expected to be in the fluid samples. A likely explanation is 
that the majority of S. aureus in the cage fluid formed clumps in the late stage of infection, which could have been verified by microscopic 
examination of the samples.
By determining metabolites concentrations and analyzing transcription of metabolic pathway genes, several major changes were 
found during infection development. Several amino acids had increasing concentrations in course of the infection as detected by NMR 
in the cage fluids (Figure 3), which could be caused by combined effects of exoenzymes, toxins and immune response. In the human PJI 
[14], we observed even higher concentrations of these amino acids. The free amino acids were likely taken up by S. aureus and utilized as 
indicated by the elevated transcript level of several amino acid catabolic pathways (Figure 5 and 6).
Upregulation of these pathways was also observed in the human PJI sample [14]. S. aureus has to grow on other carbon sources when 
glucose is limited such as in abscesses. Halsey., et al. has shown glutamate and amino acids that serve as substrates for glutamate synthesis 
are major carbon sources during growth, while other amino acids that generate pyruvate are important for ATP synthesis [28].
Oxygen limited condition after infection initiation was indicated by both elevated concentrations of fermentation products compared 
with before infection (Figure 4) and increased transcript level of several fermentation pathways in vivo compared with in vitro cultures 
(Figure 5). This was also observed in human PJI [14]. Both host and the microorganisms consume oxygen during infection, and hypoxia 
is known to be associated with a number of diseases including infection [29.30]. In human, hypoxia generally promotes the activities of 
innate immune cells while suppressing the response of the adaptive immune system [30]. However, oxygen concentration is crucial for 
host healing [31].
Ammonia production related metabolic pathways had higher transcript level on infection day 7 and 9. Production of ammonia is 
suggested to facilitate pH homeostasis during infection and is known to be a strategy employed by bacteria to neutralize acidic environment 
[32].
Responses of S. aureus towards acid stress was studied previously by Rode., et al. [33], who found a high concentration of lactic acid 
induces a response from S. aureus different from other acids at low (pH = 4.5). In the growth medium (pH = 4.5) acidified with acetic acid, 
HCl or lactic acid, only pH in cultures acidified with lactic acid gradually increased to 7.5 through accumulation of ammonium and the 
removal of acid groups [33]. The metabolites analysis of cage fluids showed that lactate concentration increased significantly from before 
infection to infection day 3 and topped on day 9 (Figure 4). This may explain the increased expression of ammonia production pathways 
over time.
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The overall picture of the transcription response of S. aureus to the in vivo environment revealed increased expression of multiple 
virulence genes upon infection, amino acids catabolism, and regulation of responses towards hypoxic and acidic environment during 
infection.
Moxifloxacin treatment did not eradicate infection in any of the six animals in agreement with the general observation that implant-
related infection cannot be cured by antibiotics alone. Seven days after termination of moxifloxacin treatment, the overall expression 
profile of S. aureus resembled that of infection day 3 although many genes were differentially expressed (Figure 7). We found it interesting 
that DRNA pathway was more transcribed in the Treat14 group than any other time. Ammonia produced by this pathway can be used for 
neutralizing acidic environment. Additionally, this pathway has been shown to be an important fitness factor in hypoxic environments in 
the presence of nitrate [34].
Our study illustrates that the bacterial gene expression is dynamic during infection development and in response to antibiotic 
treatment. Both virulence genes and genes involved in metabolic processes were actively regulated in response to changing environment 
in vivo. Therefore, similar to in vitro bacterial growth experiment, a single in vivo sample is unlikely to give a true picture of how bacteria 
behave during infection, thus should be interpreted with caution.
Conclusion
In conclusion, our study show that S. aureus adjusts its expression profile, both virulence genes and metabolic pathways, in response to 
environmental changes during infection. The transcriptome and metabolome analyses indicate the environment within the subcutaneous 
cages to be anaerobic and acidic. The bacteria navigated by regulating several pathways responsible for maintaining pH homeostasis by 
ammonia production, and the fermentation pathways from pyruvate were active. The resemblance between the human and the guinea 
pig infections and the distance to the in vitro culture expressions profiles underline the need and usefulness of further investigation of S. 
aureus infection in vivo.
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